TTE (TTE)
Quantitative Summary
DeterministicFinancial health is average: Piotroski 5/9, Altman Z 1.6.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe capital allocation efficiency of TTE demonstrates a robust spread between its Return on Invested Capital and the Weighted Average Cost of Capital at 3.8%, indicating that deployed equity generates returns exceeding the cost of financing by a meaningful margin. This operational strength is underpinned by a solid gross margin profile of 28.4% combined with a net margin of 7.2%, suggesting effective cost management despite current revenue contraction of -6.8%. Financial health metrics present a mixed but generally positive picture; the company maintains a strong Beneish M-Score of -2.79, signaling low earnings manipulation risk and high accounting quality, while its Piotroski F-Score of 5/9 reflects moderate financial stability without recent deterioration in balance sheet fundamentals or operating cash flow generation.
Valuation metrics suggest the market is pricing this stock at a discount relative to intrinsic value models, with the current P/E ratio of 15.4x trading below the DCF-derived fair value estimate of $81. This disparity implies that investors are currently assigning lower growth expectations than what might be warranted by the company's underlying capital efficiency and margin durability, potentially creating a valuation gap if revenue trends stabilize or improve. The absence of significant insider buying or selling over the last 90 days indicates neutral sentiment among management regarding current ownership levels, offering no clear directional signal from internal stakeholders at this juncture.
The risk profile is characterized by declining top-line growth and an Altman Z-Score of 1.6, which approaches the threshold typically associated with increased distress risk in manufacturing or industrial sectors. While the positive ROIC-WACC spread provides a buffer against margin compression, the combination of negative revenue momentum and a Z-score below 2.0 warrants close monitoring for potential liquidity constraints or credit rating downgrades that could impact future financing costs.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 6% | 7.2% | 9.2% |
|---|---|---|---|
| 2% | $76 | $56 | $38 |
| 3% | $100 | $69 | $44 |
| 4% | $148 | $90 | $52 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=7.2%, terminal growth 3%. Fair value $69 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like VGK or VYMI, the fund manager is mechanically forced to buy or sell TTE shares regardless of TTE's individual fundamentals. We estimate $5.2B of passive capital is structurally linked to TTE through 8 tracked ETFs. This substantial passive exposure means that ETF inflows and outflows — not company fundamentals — can dominate daily volume on this stock.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in TTE to visualize passive redemption contagion across ETFs and collateral stocks.
If TTE (TTE) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies SAMSUNG ELECTR GDR REG S (SMSN) as the most exposed collateral stock, sharing 2 ETFs with TTE. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 8 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
TTE Ownership Dynamics
ETFs with Highest TTE Exposure
Float lock-up computed from 8 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
TTE Capital Efficiency
How efficiently does TTE convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
TTE converts 27% of its EBITDA into free cash flow, a moderate conversion rate — significant EBITDA is consumed by capital expenditures, working capital changes, or interest payments. The 73% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 2.8% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-14 | 548 | $91.37 | $50,070.76 |
| 2026-05-12 | 130 | $90.69 | $11,789.7 |
| 2026-05-07 | 10,868 | $89.96 | $977,685.28 |
| 2026-05-06 | 36,068 | $93.60 | $3.4M |
| 2026-04-22 | 73,200 | $88.37 | $6.5M |
| 2026-04-21 | 4,400 | $87.31 | $384,164 |
| 2026-04-20 | 5,650 | $87.07 | $491,945.5 |
| 2026-04-17 | 4,535 | $90.74 | $411,505.9 |
| 2026-04-16 | 427 | $87.06 | $37,174.62 |
| 2026-04-13 | 29,681 | $92.65 | $2.7M |
| 2026-04-10 | 154 | $89.93 | $13,849.22 |
| 2026-04-09 | 351 | $89.45 | $31,396.95 |
| 2026-04-06 | 9,845 | $92.39 | $909,579.55 |
| 2026-04-02 | 542 | $89.78 | $48,660.76 |
| 2026-04-01 | 240 | $90.98 | $21,835.2 |
| 2026-03-31 | 737 | $91.55 | $67,472.35 |
| 2026-03-26 | 3,690 | $89.26 | $329,369.4 |
| 2026-03-25 | 89,098 | $88.79 | $7.9M |
| 2026-03-23 | 1,591 | $88.75 | $141,201.25 |
| 2026-03-20 | 9,047 | $90.06 | $814,772.82 |
| 2026-03-19 | 74 | $86.90 | $6,430.6 |
| 2026-03-18 | 23,172 | $86.04 | $2.0M |
| 2026-03-05 | 267,859 | $76.92 | $20.6M |
| 2026-02-26 | 999 | $79.49 | $79,410.51 |
| 2026-02-25 | 31,494 | $79.11 | $2.5M |
| 2026-02-24 | 55,317 | $77.83 | $4.3M |
| 2026-02-23 | 102,304 | $77.88 | $8.0M |
| 2026-02-20 | 90,575 | $77.83 | $7.0M |
| 2026-02-19 | 36,833 | $77.35 | $2.8M |
| 2026-02-18 | 11,152 | $76.52 | $853,351.04 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare TTE to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.